DIN 02312263 — CESAMET 0.25 MG
CESAMET is a capsule of Nabilone marketed by BAUSCH HEALTH, CANADA INC.. The full Nabilone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02312263
- Brand name
- CESAMET
- Active ingredient
- Nabilone
- Strength
- 0.25 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Synthetic cannabinoid (antiemetic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Nabilone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02256193 | CESAMET | 0.5 MG | CAPSULE | BAUSCH HEALTH, CANADA INC. | MARKETED |
| 00548375 | CESAMET | 1 MG | CAPSULE | BAUSCH HEALTH, CANADA INC. | MARKETED |
| 02380897 | PMS-NABILONE | 0.25 MG | CAPSULE | PHARMASCIENCE INC | MARKETED |
| 02380900 | PMS-NABILONE | 0.5 MG | CAPSULE | PHARMASCIENCE INC | MARKETED |
| 02380919 | PMS-NABILONE | 1.0 MG | CAPSULE | PHARMASCIENCE INC | MARKETED |
| 02392925 | TEVA-NABILONE | 0.25 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED |
| 02384884 | TEVA-NABILONE | 0.5 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED |
| 02384892 | TEVA-NABILONE | 1.0 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED |